You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Interactive E-Learning to Promote Successful Postsecondary Employment Outcomes for Students with Intellectual Disabilities

    SBC: 3-C Institute for Social Development, Inc.            Topic: NA

    This project creates a Web-based Occupational Resource Kit (W.O.R.K.), the first self-paced, adaptive job skills intervention designed specifically to meet the learning styles and social-emotional needs of students with intellectual disabilities. W.O.R.K. enhances students’ preparedness for postsecondary employment, optimizing the likelihood of success in the workforce following completion of hi ...

    SBIR Phase II 2015 Department of Health and Human ServicesAdministration for Community Living
  2. CHEMOENZYMATIC SYNTHESIS OF HEPARAN SULFATE OLIGOSACCHARIDES

    SBC: Glycan Therapeutics Corporation            Topic: NCI

    The goal of this contract is to synthesize a heparan sulfate HS library consisting of structurally homogeneous oligosaccharides in response to an SBIR contract call from NCl Chemically Defined Glycan Libraries The Contractor specializes in the synthesis of structurally diverse HS oligosaccharides The Contractor has built an innovative chemoenzymatic method for Glycan synthesis Polymeri ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  3. IGF OT IGF Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging SBIR Topic Phase II

    SBC: Adamas Nanotechnologies, Inc.            Topic: NHLBI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  4. IGF OT IGF ARISE AN ONLINE RELAPSE PREVENTION TOOL FOR SUBSTANCE ABUSERS N DA POP SEPTEMBER SEPTEMBER SUPPLEMENTAL W IN SCOPE

    SBC: 3-C Institute for Social Development, Inc.            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. IGF OT IGF MULTIPLEXED BIOMARKER ASSAY FOR CLASSIFICATION OF PATIENTS WITH SYSTEMIC SCLEROSIS

    SBC: CELDARA MEDICAL, LLC            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  6. Development of a novel method for inhibiting diabetic retinopathy

    SBC: CMP Tarnhelm Partners            Topic: N

    DESCRIPTION provided by applicant The long term objective of this project study is to develop a monoclonal antibody that inhibits the progression of diabetic retinopathy Insulin like growth factor I IGF I has been implicated in both endothelial dysfunction as well as the proliferative phase of the disease but IGF I concentrations in retina are not increased During hyperglycemia IGF I activa ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma

    SBC: Annias Immunotherapeutics, Inc.            Topic: NCI

    DESCRIPTION provided by applicant Malignant primary brain tumors represent the most frequent cause of cancer death in children and young adults and account for more deaths than cancer of the kidney or melanoma Glioblastoma GBM is uniformly lethal and current therapy is non specific and produces a median overall survival of andlt months In contrast immunotherapeutic approaches are exq ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  8. C2E2-An Orally Administered Radionuclide Decorporation Agent

    SBC: Capture Pharmaceuticals, Inc.            Topic: R

    DESCRIPTION provided by applicant Capture Pharmaceuticals Inc is developing a drug called C E for treatment of individuals who have been contaminated by radioactive transuranic elements either by accident or following a nuclear terrorism event C E is a radionuclide decorporation agent that works by binding these elements in the bloodstream and enhancing their elimination before they can b ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Development of novel anti-biofilm compounds for treating chronic wounds

    SBC: AGILE SCIENCES, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Chronic wounds that fail to respond to traditional therapeutic interventions afflict millions of people each year and direct costs associated with treating these wounds are estimated at $ billion annually in the U S alone Eradication of pathogenic bacteria that have colonized chronic wounds is complicated by the propensity of these bacteria to form biof ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Medical Images HTML and Clinical Trial Remote Collaboration

    SBC: HEART IMAGING TECHNOLOGIES, LLC            Topic: NHLBI

    DESCRIPTION provided by applicant Medical drugs and devices are regulated by the U S Food and Drug Administration FDA based on data from multicenter clinical trials In U S spending on clinical trials was approximately $ billion Over the past decade the efficiency of clinical trials has been improved by electronic data capture EDC systems whose use has increased from to ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government